Lexicon Pharmaceuticals Inc (LXRX) Down 3.73% in Premarket Trading

Lexicon Pharmaceuticals Inc (LXRX) has fallen Thursday morning, with the stock declining -3.73% in pre-market trading to 1.29. LXRX's short-term technical score of 3 indicates that the stock has traded less bullishly over the last month than 97% of stocks on the market. In the Biotechnology industry, which ranks 130 out of 146 industries, Lexicon Pharmaceuticals Inc ranks higher than 6% of stocks. Lexicon Pharmaceuticals Inc has risen 31.37% over the past month, closing at $1.05 on October 5. During this period of time, the stock fell as low as $1.00 and as high as $1.43. LXRX has an average analyst recommendation of Buy. The company has an average price target of $5.55.

LXRX has an Overall Score of 40. Find out what this means to you and get the rest of the rankings on LXRX!

See Full LXRX Report

Lexicon Pharmaceuticals Inc has a Long-Term Technical rank of 25. This means that trading over the last 200 trading days has placed the company in the lower half of stocks with 75% of the market scoring higher. In the Biotechnology industry which is number 129 by this metric, LXRX ranks better than 129% of stocks.

Important Dates for Investors in LXRX:

-Lexicon Pharmaceuticals Inc is set to release earnings on 2023-11-08. Over the last 12 months, the company has reported EPS of $-0.52. -We do not have a set dividend date for Lexicon Pharmaceuticals Inc at this time. Click Here To Get The Full Report on Lexicon Pharmaceuticals Inc (LXRX)